Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX).
- Disclosed ownership: 3.5%.
- Date of event: 03 Jul 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 3.5% ownership in CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX) on 03 Jul 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 1.9% | 3,074,013 | 0 | 3,074,013 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 1.9% | 3,074,013 | 0 | 3,074,013 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 1.5% | 2,351,446 | 0 | 2,351,446 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 1.5% | 2,351,446 | 0 | 2,351,446 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.2% | 270,616 | 0 | 270,616 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.2% | 270,616 | 0 | 270,616 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 3.3% | 5,425,459 | 0 | 5,425,459 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 3.5% | 5,769,231 | 0 | 5,769,231 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 3.5% | 5,769,231 | 0 | 5,769,231 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 3.5% | 5,769,231 | 0 | 5,769,231 | /s/ Mark N. Lampert | Mark N. Lampert |